Head and Neck Cancer

Practical Radiation Oncology

PRO 02 (Live SA-CME) - PRO - Head and Neck Cancer (HPV + ve)

10/20/2018
10:30 AM - 12:00 PM
Location: Room 304

Session Type: Educational
1.50 AMA PRA Category 1 Credits™
1.50 CAMPEP Credits
1.50 MDCB Credits

This event is ticketed and requires separate registration and an additional fee. Space is limited, so please register early. Please note that events and fees are subject to change.

This session will discuss optimal evaluation and treatment of patients with HPV-positive oropharynx cancer. In January 2018, AJCC 8 became the new staging system, with profound differences for HPV-positive oropharynx cancers; the new staging and its implications will be discussed. The session will review the best practices for patient evaluation and evidence-based (and guideline-based) management of HPV-positive cancers in 2018. The expected prognosis and toxicity patterns will be reviewed, in addition to their management. As well, current clinical trials looking at treatment de-escalation strategies will be reviewed, with recommendations on what should be incorporated into practice now on- and off-protocol. The indications for chemoradiation versus radiation alone, the optimal treatment in the postoperative setting after transoral robotic surgery (TORS) and contouring recommendations will be discussed with an emphasis on maximizing outcomes and reducing treatment related toxicity. Didactic information will be strengthened with case-based discussions and vignettes to illustrate real-world implications of these decisions and recommendations.

Learning Objectives:

Presentations:

Beth Beadle, MD, PhD

Stanford University

Disclosure:
Employment
Stanford University: Associate Professor: Employee

Compensation
NIH: Research Grants

Leadership
American Radium Society: Secretary

Biography:
Beth Beadle is an Associate Professor of Radiation Oncology and Director of Head and Neck Radiation Oncology at Stanford University. She also serves as the Director of Clinical Research. Her research interests are in using technology to improve patient care, with regard to outcomes and toxicity, as well as to expand access to high-quality radiation throughout the world.

Presentation(s):

Send Email for Beth Beadle


Assets

PRO 02 (Live SA-CME) - PRO - Head and Neck Cancer (HPV + ve)



Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for PRO 02 (Live SA-CME) - PRO - Head and Neck Cancer (HPV + ve)